Existing user? Sign in Start 7-day access →
Stocks · GLENMARK · F&O

Glenmark Pharmaceuticals share price & delivery.

Last close · 19 Oct 2026
₹2,210.20 -0.74%
Sector: Pharma & healthcare · RS rating 70
1W-3.2%1M-8.5%3M-1.3%6M-1.7%1Y+16.8%
52-week range
₹1,792.60-12.9% from the high₹2,537.60
Open in TradingView ↗

Price, volume and delivery

Candles adjusted for splits and bonuses. In the lower panel, the grey bar is the day’s volume and the coloured bar is the part that was delivered; bright green marks big-buyer days (delivered shares 3× the stock’s normal or more, with a normal-or-higher delivery %).

Glenmark Pharma stock DNA

Where Glenmark Pharma sits among the 1,422 most traded NSE stocks, on a 0–100 scale: 0 is the lowest of all of them, 100 the highest. From the last year of daily data. The first row is the RS rating used on our relative strength ranking.

Relative strength (RS rating)12-month return, latest quarter counted twice
Weak
Strong
70/100
Volatility27% a year
Calm
Wild
10/100
Daily range2.6% high to low
Tight
Wide
17/100
Opening gaps8% of days gap 1%+
Rare
Often
2/100
Delivery49% of volume delivered
Traders
Holders
54/100
Liquidity₹111 Cr a day
Thin
Deep
88/100
1-year return+16.8%
Laggard
Leader
72/100
Gap-ups of 1%+ (1 year)1354% filled the same day
Gap-downs of 1%+786% filled the same day
Up days53%of the last 250 sessions
Streak2 downsessions in a row

How Glenmark Pharma usually moves

Every session of the last year by size of move. The white line is the last session.

-6.0% to -5.5%: 1 days-5.0% to -4.5%: 1 days-4.5% to -4.0%: 3 days-4.0% to -3.5%: 5 days-3.5% to -3.0%: 3 days-3.0% to -2.5%: 4 days-2.5% to -2.0%: 4 days-2.0% to -1.5%: 17 days-1.5% to -1.0%: 15 days-1.0% to -0.5%: 28 days-0.5% to +0.0%: 36 days+0.0% to +0.5%: 43 days+0.5% to +1.0%: 27 days+1.0% to +1.5%: 14 days+1.5% to +2.0%: 21 days+2.0% to +2.5%: 8 days+2.5% to +3.0%: 8 days+3.0% to +3.5%: 5 days+3.5% to +4.0%: 3 days+4.0% to +4.5%: 1 days+4.5% to +5.0%: 2 days+5.0% to +5.5%: 1 days-6%-4%-2%+0%+2%+4%+6%Dashed lines: a normal day, ±1.7%Last session -0.74%

Best day 10 Mar 2026 (+5.11%), worst 22 May 2026 (-5.60%).

Glenmark Pharma vs NIFTY 50, one year

Both start at 100. The shaded gap is how far Glenmark Pharma is ahead of or behind the market.

100Dec 25Mar 26Jun 26Sep 26Glenmark Pharm +17.6%NIFTY 50 -8.6%

Peers in Pharma & healthcare

The most traded stocks in the same sector. All Pharma & healthcare stocks and the sector’s trend →

Divi's Labs+38.50% 1YRS 88Apollo Hospitals-0.76% 1YRS 52Laurus Labs+135.66% 1YRS 97Sun Pharma+5.36% 1YRS 56Dr Reddy's+0.42% 1YRS 61Max Healthcare-28.54% 1YRS 14Torrent Pharma+29.43% 1YRS 72Lupin+0.10% 1YRS 42

Delivery and big-buyer days

Delivered shares change owners for real; intraday trades don’t. Days when delivery jumps far above normal often mean large investors were buying or selling.

Delivery, last session42%1.21 L shares
Average, 60 sessions49%1-year median 47%
Big-buyer days, 1 year8delivery 3× normal or more

Delivery calendar, last 12 months

Each square is a session. The brighter the green, the more shares were delivered compared with Glenmark Pharma’s normal. Hover or tap a square for the day.

MWFNovDecJanFebMarAprMayJunJulAugSepOct
Hover a square
QuietBelow normalNormalHighBig-buyer day

Latest big-buyer days

What the price did on the day and five sessions later. Past moves only.

DateDeliveredvs normalDelivery %Day5 days later
30 Sep 20267.12 L3.0×56%-4.37%-6.10%
29 Sep 20268.40 L3.5×66%+4.98%-6.52%
29 Jun 20267.54 L3.0×53%+1.49%+3.86%
30 Mar 20267.37 L3.7×62%-1.79%+1.96%
2 Feb 20267.56 L3.8×51%-1.01%+2.81%
30 Dec 202518.45 L6.1×80%+1.00%+2.21%
17 Nov 202524.78 L7.2×40%-1.41%-1.42%
12 Nov 202512.93 L4.0×71%+1.68%-0.38%

Glenmark Pharma timeline

Everything that happened to Glenmark Pharma, newest first: deals, promoter filings, results, big-buyer days, new highs and big moves.

  • September 2026
  • 30 Sep
    Big-buyer day: 7.12 L shares delivered, 3.0× normal56% of the day’s volume was delivered; the price closed -4.37%.
  • 29 Sep
    Big-buyer day: 8.40 L shares delivered, 3.5× normal66% of the day’s volume was delivered; the price closed +4.98%.
  • August 2026
  • 31 Aug
    Dividend - Rs 2.50 Per ShareEx-date: buy before this day to be entitled. From NSE’s corporate actions.
  • 27 Aug
    New 52-week high at ₹2,484.00First new high in 83 sessions.
  • July 2026
  • 28 Jul
    Q1 FY27 results: -0.52% on the dayPublished 27 Jul, 16:13 (after the close); opening gap +0.18%.
  • June 2026
  • 29 Jun
    Big-buyer day: 7.54 L shares delivered, 3.0× normal53% of the day’s volume was delivered; the price closed +1.49%.
  • May 2026
  • 22 May
    Fell 5.6% in one sessionClosed at ₹2,259.10, about 3.2× a normal day’s move.
  • 4 May
    Q4 FY26 results: -0.52% on the dayPublished 30 Apr, 16:58 (after the close); opening gap +1.16%.
  • April 2026
  • 23 Apr
    New 52-week high at ₹2,359.40First new high in 27 sessions.
  • March 2026
  • 30 Mar
    Big-buyer day: 7.37 L shares delivered, 3.7× normal62% of the day’s volume was delivered; the price closed -1.79%.
  • 11 Mar
    New 52-week high at ₹2,297.90First new high in over 20 sessions.
  • February 2026
  • 2 Feb
    Big-buyer day: 7.56 L shares delivered, 3.8× normal51% of the day’s volume was delivered; the price closed -1.01%.
  • January 2026
  • 23 Jan
    Q3 FY26 results: -1.48% on the dayPublished 22 Jan, 16:48 (after the close); opening gap +0.14%.
  • December 2025
  • 30 Dec
    Big-buyer day: 18.45 L shares delivered, 6.1× normal80% of the day’s volume was delivered; the price closed +1.00%.
  • November 2025
  • 17 Nov
    Big-buyer day: 24.78 L shares delivered, 7.2× normal40% of the day’s volume was delivered; the price closed -1.41%.
  • 12 Nov
    Big-buyer day: 12.93 L shares delivered, 4.0× normal71% of the day’s volume was delivered; the price closed +1.68%.
  • October 2025
  • 20 Oct
    Q2 FY26 results: -0.49% on the dayPublished 17 Oct, 16:03 (after the close); opening gap -0.21%.
  • 3 Oct
    Interim Dividend - Rs 2.50 Per ShareEx-date: buy before this day to be entitled. From NSE’s corporate actions.
  • September 2025
  • 15 Sep
    Dividend - Rs 2.50 Per ShareEx-date: buy before this day to be entitled. From NSE’s corporate actions.
  • July 2025
  • 28 Jul
    Q1 FY26 results: -0.04% on the dayPublished 25 Jul, 16:52 (after the close); opening gap +0.08%.
  • June 2025
  • 5 Jun
    Big-buyer day: 10.14 L shares delivered, 3.2× normal44% of the day’s volume was delivered; the price closed +4.76%.
  • 4 Jun
    Big-buyer day: 10.39 L shares delivered, 3.5× normal68% of the day’s volume was delivered; the price closed -0.08%.
  • 3 Jun
    Big-buyer day: 11.43 L shares delivered, 4.1× normal44% of the day’s volume was delivered; the price closed +1.10%.
  • May 2025
  • 26 May
    Big-buyer day: 7.99 L shares delivered, 3.0× normal38% of the day’s volume was delivered; the price closed -2.12%.
  • 26 May
    Q4 FY25 results: -2.12% on the dayPublished 23 May, 20:58 (after the close); opening gap -3.53%.
  • February 2025
  • 17 Feb
    Q3 FY25 results: +3.84% on the dayPublished 14 Feb, 20:13 (after the close); opening gap -0.23%.
  • November 2024
  • 18 Nov
    Q2 FY25 results: -3.13% on the dayPublished 15 Nov, 13:36 (on a non-trading day); opening gap +1.06%.

F&O snapshot

Near-month future and options for 19 Oct 2026. OI build-up for all stocks →

Futures₹2,212.70-0.87% on the day
Open interest1.15 Cr+0.31% on the day
Build-upShort Buildupprice and OI together
PCR0.53all expiries 0.52
Max pain₹2,2802026-10-27 expiry
Market-wide limit used70%ban at 95%

Futures price and open interest

Near-month futures and total futures open interest since Jul 2024. Rising OI with a rising price is fresh buying; with a falling price, fresh selling.

Last 20 sessions
Long build-up Short build-up Short covering Long unwinding

PCR and max pain history

Biggest open interest for the 27 Oct expiry: calls at 2,300 (often read as resistance), puts at 2,200 (often read as support).

PCR for all stocks → · Max pain record → · OI build-up & futures screener →

Results-day moves

How Glenmark Pharma moved on each quarterly results day. Every result since 2007 →

Typical move±2.4%last 12 results
vs a normal day2.7×bigger than usual
Closed higher40%of 77 results
+4%-4%+9%-9%Q2 FY22: +2.28% on 15 Nov 2021+2.3Q2 FY22Q3 FY22: -2.29% on 14 Feb 2022-2.3Q4 FY22: +2.90% on 30 May 2022+2.9Q4 FY22Q1 FY23: -0.05% on 12 Aug 2022-0.1Q2 FY23: +4.09% on 14 Nov 2022+4.1Q2 FY23Q3 FY23: +5.54% on 13 Feb 2023+5.5Q4 FY23: -2.93% on 22 May 2023-2.9Q4 FY23Q1 FY24: -0.46% on 14 Aug 2023-0.5Q2 FY24: -1.93% on 12 Nov 2023-1.9Q2 FY24Q3 FY24: +1.64% on 15 Feb 2024+1.6Q4 FY24: +8.06% on 27 May 2024+8.1Q4 FY24Q1 FY25: +5.00% on 16 Aug 2024+5.0Q2 FY25: -3.13% on 18 Nov 2024-3.1Q2 FY25Q3 FY25: +3.84% on 17 Feb 2025+3.8Q4 FY25: -2.12% on 26 May 2025-2.1Q4 FY25Q1 FY26: -0.04% on 28 Jul 2025-0.0Q2 FY26: -0.49% on 20 Oct 2025-0.5Q2 FY26Q3 FY26: -1.48% on 23 Jan 2026-1.5Q4 FY26: -0.52% on 4 May 2026-0.5Q4 FY26Q1 FY27: -0.52% on 28 Jul 2026-0.5

Best and worst months

Average return in each calendar month since 2000. Full share price history →

Jan: average -5.38%, higher in 35% of years-5.4JanFeb: average -1.63%, higher in 46% of years-1.6FebMar: average -0.03%, higher in 48% of years-0.0MarApr: average +9.38%, higher in 81% of years+9.4AprMay: average +1.77%, higher in 56% of years+1.8MayJun: average +1.47%, higher in 44% of years+1.5JunJul: average +5.29%, higher in 70% of years+5.3JulAug: average +1.57%, higher in 48% of years+1.6AugSep: average +2.62%, higher in 56% of years+2.6SepOct: average +1.32%, higher in 46% of years+1.3OctNov: average +4.05%, higher in 62% of years+4.1NovDec: average +8.14%, higher in 73% of years+8.1Dec

My notes on Glenmark Pharma

Private: saved only in this browser, never sent to us.

Questions

What is the 52-week high and low of Glenmark Pharma?
Over the last 52 weeks, Glenmark Pharmaceuticals (GLENMARK) traded between ₹1,792.60 and ₹2,537.60 (adjusted for splits and bonuses). The last close of ₹2,210.20 on 19 Oct 2026 is 12.9% below the high.
What is the delivery percentage of Glenmark Pharma?
On 19 Oct 2026, 42.3% of Glenmark Pharma’s traded shares were delivered. The 60-session average is 49.4%, and its median over the last year is 46.7%.
How volatile is Glenmark Pharma?
Glenmark Pharma’s daily moves over the last year add up to 27% annual volatility, higher than 10% of the 1,422 most traded NSE stocks. Its average day spans 2.6% from high to low.
How much does Glenmark Pharma move on results day?
Over its last 12 quarterly results, Glenmark Pharma moved ±2.4% on average on the reaction day, about 2.7× a normal day, and closed higher 40% of the time.

Data from NSE’s daily files, adjusted for splits and bonuses. Past behaviour is not a forecast. This is information, not investment advice; ChartMine is not a SEBI-registered adviser.

See it live on your chart.ChartMine for TradingView.

Start 7-day access →How it works